[1]吕玉寰 李蓉.床旁检测设备在早期诊断糖尿病神经病变中的价值[J].国际内分泌代谢杂志,2023,43(05):388-391.[doi:10.3760/cma.j.cn121383-20230118-01028]
　Lyu Yuhuan,Li Rong..Detection value of point-of-care devices in the early diagnosis of diabetes neuropathy[J].International Journal of Endocrinology and Metabolism,2023,43(05):388-391.[doi:10.3760/cma.j.cn121383-20230118-01028]
点击复制

床旁检测设备在早期诊断糖尿病神经病变中的价值()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年05期
页码:
388-391
栏目:
综述
出版日期:
2023-09-20

文章信息/Info

Title:
Detection value of point-of-care devices in the early diagnosis of diabetes neuropathy
作者:
吕玉寰 李蓉
重庆医科大学附属第一医院内分泌科,重庆 400016
Author(s):
Lyu Yuhuan;  Li Rong.
Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
关键词:
糖尿病神经病变;  床旁检测设备;  早期诊断
Keywords:
Diabetic neuropathy;  Point-of-care devices;  Early diagnosis
DOI:
10.3760/cma.j.cn121383-20230118-01028
摘要:
糖尿病周围神经病变(DPN)是糖尿病常见的慢性并发症,可能导致严重的临床后果,如足部溃疡、截肢和神经性疼痛。这使得患者生活质量严重下降,同时对医疗保健成本和社会造成了沉重的负担。DPN在早期阶段通常无症状,而一旦出现明显症状,疾病将难以逆转。因此,早期筛查和诊断对预防和延缓DPN的发生发展至关重要。本综述旨在评估目前可用的早期诊断DPN的床旁检测设备(POCDs),包括检测大纤维神经病变的DPNcheck和VibraTip以及检测小纤维神经的Neuropad和Sudoscan。DPNcheck主要检测腓肠神经的电生理,VibraTip检测振动觉,而Neuropad和Sudoscan均检测泌汗功能。这些设备的使用能促进更大规模患者的筛查和提高DPN的早期诊断。
Abstract:
Diabetes peripheral neuropathy(DPN)is a common chronic complication of diabetes, and could lead to serious sequelae, such as foot ulcer, amputation and neuropathic pain, which severely reduce the quality of life of patients, and meanwhile, significantly burdens the healthcare system and society. DPN is typically asymptomatic in its early stages, but the disease will be difficult to reverse once obvious symptoms appear. Therefore, early screening and diagnosis are the key to prevent and reduce the incidence of DPN. This review aims to evaluate the currently available point of care devices(POCDs)for early diagnosis of DPN, including DPNcheck and VibraTip for detecting large fiber neuropathy, as well as Neuropad and Sudoscan for detecting small fiber neuropathy. DPNcheck mainly detects the electrophysiology of the sural nerve, VibraTip detects vibration sensation, while Neuropad and Sudoscan both detect sudomotor function. The use of these devices can facilitate larger patient screening and improve early diagnosis of DPN.

参考文献/References:

[1] 吴静,时立新.糖尿病神经病变诊治专家共识(2021年版)要点说明[J].中华糖尿病杂志,2021,13(6):S535-539.DOI:10.3760/cma.j.cn115791-20210510-00259.
[2] Ziegler D,Keller J,Maier C,et al.Diabetic Neuropathy[J].Exp Clin Endocrinol Diabetes,2021,129(S 01):S70-S81.DOI:10.1055/a-1284-6245.
[3] Bus SA,Sacco ICN,Monteiro-Soares M,et al.Guidelines on the prevention of foot ulcers in persons with diabetes(IWGDF 2023 update)[J].Diabetes Metab Res Rev,2023,e3651.DOI:10.1002/dmrr.3651.
[4] Pop-Busui R,Boulton AJ,Feldman EL,et al.Diabetic neuropathy:a position statement by the American Diabetes Association[J].Diabetes Care,2017,40(1):136-154.DOI:10.2337/dc16-2042.
[5] Kamiya H,Shibata Y,Himeno T,et al.Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy:a quantitative,but easy-to-use,prediction model[J].J Diabetes Investig,2021,12(4):583-591.DOI:10.1111/jdi.13386.
[6] Kural MA,Andersen ST,Andersen NT,et al.The utility of a point-of-care sural nerve conduction device for detection of diabetic polyneuropathy:a cross-sectional study[J].Muscle Nerve,2019,59(2):187-193.DOI:10.1002/mus.26361.
[7] Shibata Y,Himeno T,Kamiya T,et al.Validity and reliability of a point-of-care nerve conduction device in diabetes patients[J].J Diabetes Investig,2019,10(5):1291-1298.DOI:10.1111/jdi.13007.
[8] Binns-Hall O,Selvarajah D,Sanger D,et al.One-stop microvascular screening service:an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot[J].Diabet Med,2018,35(7):887-894.DOI:10.1111/dme.13630.
[9] Dhana Lakshmi SKS,Ramakrishna CK,SatyaSree D,et al.Evaluation of the accuracy of vibration sense with VibraTip? as a tool to determine the level of anesthesia following subarachnoid block and its correlation with the pinprick sensation[J].J Anaesthesiol Clin Pharmacol,2021,37(1):97-101.DOI:10.4103/joacp.JOACP_258_18.
[10] Papanas N,Pafili K,Demetriou M,et al.The diagnostic utility of VibraTipfor distal symmetrical polyneuropathy in type 2 diabetes mellitus[J].Diabetes Ther,2020,11(1):341-346.DOI:10.1007/s13300-019-00738-4.
[11] Tentolouris A,Tentolouris N,Eleftheriadou I,et al.The performance and interrater agreement of vibration perception for the diagnosis of loss of protective sensation in people with diabetes mellitus[J].Int J Low Extrem Wounds,2023,22(1):72-76.DOI:10.1177/1534734621994058.
[12] Pasangha E,George B,Jayalakshmi V,et al.The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral footof patients admitted with a diabetic foot ulcer[J].Diabetes Metab Syndr,2021,15(3):857-862.DOI:10.1016/j.dsx.2021.03.023.
[13] de Azevedo Vieira ARS,Porto-Dantas LB,do Prado Romani FA,et al.Autonomic neuropathic symptoms in patients with diabetes:practical tools forscreening in daily routine[J].Diabetol Metab Syndr,2023,15(1):83.DOI:10.1186/s13098-023-01036-7.
[14] Hewitt N.The Neuropad test for the early detection of diabetic peripheral neuropathy[EB/OL].[2017-10-13].https://www.nice.org.uk/guidance/mtg38/documents/overview-of-assessment-report.
[15] Zografou I,Iliadis F,Sambanis C,et al.Validation of neuropad in the assessment of peripheral diabetic neuropathy in patients with diabetes mellitus versus the Michigan neuropathy screening instrument,10g monofilament pplication and biothesiometer measurement[J].Curr Vasc Pharmacol,2020,18(5):517-522.DOI:10.2174/1570161117666190723155324.
[16] Rodríguez-Sánchez B,Peña-Longobardo LM,Sinclair AJ.Cost-effectiveness analysis of the neuropad device as a screening tool for early diabetic peripheral neuropathy[J].Eur J Health Econ,2020,21(3):335-349.DOI:10.1007/s10198-019-01134-2.
[17] Panagoulias GS,Eleftheriadou I,Papanas N,et al.Dryness of foot skin assessed by the visual indicator test and risk of diabetic foot ulceration:a prospective observational study[J].Front Endocrinol(Lausanne),2020,11:S625.DOI:10.3389/fendo.2020.00625.
[18] Ponirakis G,Fadavi H,Petropoulos IN,et al.Automated quantification of neuropad improves its diagnostic ability in patients with diabetic neuropathy[J].J Diabetes Res,2015,2015:847854.DOI:10.1155/2015/847854.
[19] Lin K,Wu Y,Liu S,et al.The application of sudoscan for screening microvascular complications in patients with type 2 diabetes[J].PeerJ,2022,10:e13089.DOI:10.7717/peerj.13089.
[20] García-Ulloa AC,Almeda-Valdes P,Cuatecontzi-Xochitiotzi TE,et al.Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes[J].BMJ Open Diabetes Res Care,2022,10(6):e003005.DOI:10.1136/bmjdrc-2022-003005.
[21] Goel A,Shivaprasad C,Kolly A,et al.Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy[J].PLoS One,2017,12(9):e0183973.DOI:10.1371/journal.pone.0183973.
[22] Gavan DE,Gavan A,Bondor CI,et al.SUDOSCAN,an innovative,simple and non-invasive medical device for assessing sudomotor function[J].Sensors(Basel),2022,22(19):e7571.DOI:10.3390/s22197571.
[23] Jin J,Wang W,Gu T,et al.The application of SUDOSCAN for screening diabetic peripheral neuropathy in Chinese population[J].Exp Clin Endocrinol Diabetes,2018,126(8):472-477.DOI:10.1055/s-0043-116673.
[24] Gatev T,Gateva A,Assyov Y,et al.The role of sudoscan feet asymmetry in the diabetic foot[J].Prim Care Diabetes,2020,14(1):47-52.DOI:10.1016/j.pcd.2019.05.003.

备注/Memo

备注/Memo:
通信作者:李蓉,Email:rongli232006@163.com
更新日期/Last Update: 2023-10-10